Chloroquine Phosphate
- Product NDC
- 63304-461
- 11-digit product format
- 633040461
- Labeler code
- 63304
- Product ID
- 63304-461_78f66195-aad3-4abf-bcec-7ad609fbefa7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Chloroquine Phosphate
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Ranbaxy Pharmaceuticals Inc.
- Application
- ANDA090249
- Marketing category
- ANDA
- Marketing start
- 2011-03-15
- Marketing end
- 0000-00-00
- Substance
- CHLOROQUINE PHOSPHATE
- Active strength
- 500 mg/1
- Pharmacologic classes
- Antimalarial [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 63304-461-03 | 2020-05-03 | C162847 | 48780-1 | 9d75b9d0-4a1d-f424-e053-dadaa90a57ce | abebf252-4ee0-46fb-a969-5ef0a4da414b |
| 63304-461-05 | 2020-05-03 | C162847 | 48780-1 | 9d75b9d0-4a1d-f424-e053-dadaa90a57ce | abebf252-4ee0-46fb-a969-5ef0a4da414b |
| 63304-461-26 | 2020-05-03 | C162847 | 48780-1 | 9d75b9d0-4a1d-f424-e053-dadaa90a57ce | abebf252-4ee0-46fb-a969-5ef0a4da414b |
| 63304-461-03 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-4a1d-f424-e053-dadaa90a57ce | abebf252-4ee0-46fb-a969-5ef0a4da414b |
| 63304-461-05 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-4a1d-f424-e053-dadaa90a57ce | abebf252-4ee0-46fb-a969-5ef0a4da414b |
| 63304-461-26 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-4a1d-f424-e053-dadaa90a57ce | abebf252-4ee0-46fb-a969-5ef0a4da414b |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63304-461-26 | EA - Each | 63304-461 | bc9a33a0-2f06-4ec5-bde7-732c21850d82 | 1 | 2013-02-13 |